Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5904315 | Neuropeptides | 2012 | 5 Pages |
Abstract
A polymorphism in the DPP-IV gene in patients with known CAD may increase the risk of MI. This SNP is associated with decreased plasma DPP4 level in patients with MI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Nima Aghili, Joseph M. Devaney, Lee O. Alderman, Zofia Zukowska, Stephen E. Epstein, Mary Susan Burnett,